Immunome, Inc.IMNMNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-3042.18%
↓ 395% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
-614.50%
Historical baseline
PeriodValueYoY Change
2025-3042.18%-81.7%
2024-1674.08%-738.1%
2023-199.74%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-